Health Minister Pressured to Replace Palantir Data System

Key Points

• The Health and Social Care Committee has written to Health Innovation Minister Preet Kaur Gill urging the government to abandon Palantir’s Federated Data Platform (FDP).
• MPs recommend the contract be dropped when a break clause becomes available in February 2027.
• The letter cites public concern about data security, doubts over the FDP’s actual effectiveness, and the existence of alternative solutions already in use across some NHS trusts.
• MPs warn that “serious mistrust” of Palantir among the public could deter patients from sharing medical data with the NHS.
• NHS England has walked back earlier claims that the FDP was responsible for improvements such as shorter waiting lists, saying it cannot draw firm conclusions about cause and effect.
• The government has accepted that some NHS trusts already have capabilities that go beyond what the FDP offers.
• The Committee wants details on the feasibility of appointing a new contractor by March 2027, along with information on how the government will assess whether to continue with Palantir.
• Committee Chair Layla Moran MP says the government’s case for keeping the FDP has “unravelled” and that preparations for an alternative should begin now.

Westminster (Britain Today News) July 09, 2026 – Members of Parliament have called on the government to sever ties with United States technology firm Palantir and its Federated Data Platform, urging ministers to begin searching for an alternative NHS data system without delay. In a formal letter to Health Innovation Minister Preet Kaur Gill, the cross-party Health and Social Care Committee said the FDP should be dropped when a break clause in its contract becomes available in February 2027, citing public mistrust, unproven efficacy and the availability of other options already operating within the health service.

What Has the Health and Social Care Committee Recommended?

The Health and Social Care Committee has formally recommended that the government end its arrangement with Palantir over the Federated Data Platform once the contractual break clause arrives in February 2027. The recommendation follows what the Committee describes as a recent deep-dive evidence session, during which MPs examined concerns raised about the platform’s rollout, its cost-effectiveness and its reception among patients and NHS staff. Rather than calling for an immediate termination, the Committee has framed its request as a considered, staged process: the government should use the upcoming contractual window to transition away from Palantir and towards a system, or systems, that better address the concerns raised.

Why Are MPs Concerned About Palantir’s Involvement in NHS Data?

Central to the Committee’s objection is what it describes as “serious mistrust” among members of the public towards Palantir’s role in handling NHS data. The letter warns that this mistrust is not merely a public relations issue but a practical risk to the health service’s digital ambitions. If patients become wary of how their medical information is stored, shared or used, they may become less willing to consent to their data being collected in the first place. According to the letter, this reluctance

“has the potential to deter patients from sharing their medical data with the NHS,”

which the Committee says could undermine the broader push to modernise the health service through digital tools. In effect, MPs argue that public confidence is itself a form of NHS infrastructure, and that Palantir’s association with the platform is placing that confidence at risk.

What Does the Letter to Preet Kaur Gill Actually Say?

The letter, addressed directly to Health Innovation Minister Preet Kaur Gill, lays out three central pillars of concern: data security, doubts about the FDP’s real-world efficacy, and the existence of viable alternative solutions. It does not call for the platform’s removal on ideological grounds alone, but instead builds a case rooted in evidence gathered during the Committee’s evidence session. The letter states plainly that “serious mistrust” among the public towards Palantir threatens to undercut trust in the NHS’s handling of sensitive medical information more broadly. Taken together, the letter positions itself as a considered policy intervention rather than a snap political statement, urging the Minister to treat the findings as grounds for a formal reassessment of the contract.

What Triggered the Committee’s Decision to Intervene?

The Committee’s intervention follows a dedicated evidence-gathering session in which MPs scrutinised the operation and impact of the Federated Data Platform since its introduction. It was during this process that concerns about the platform’s actual contribution to NHS performance improvements came under particular scrutiny, alongside broader questions about public perception of Palantir as a data partner for a public health system. The timing of the letter, ahead of the February 2027 break clause, suggests MPs are seeking to give the Department of Health and Social Care sufficient lead time to prepare an alternative, rather than being caught without a contingency plan when the contractual window opens.

What Is the Significance of the February 2027 Break Clause?

The break clause due in February 2027 represents the earliest formal opportunity within the existing contract for the government to exit its arrangement with Palantir without the complications that might arise from ending the agreement outside of its agreed terms. The Committee’s recommendation is explicitly tied to this date, with MPs urging the government to use the break clause as the moment to step away from the FDP. This timing also underpins the Committee’s other requests, including its call for clarity on whether a replacement contractor could realistically be in place by March 2027, just one month after the break clause becomes active.

What Has NHS England Said About the FDP’s Performance Claims?

One of the more significant developments underpinning the Committee’s scepticism concerns the NHS’s own published claims about the platform’s impact. The NHS website had previously stated that there was proof of performance improvements since the FDP’s introduction, pointing to outcomes such as reduced waiting lists and an increase in the number of procedures carried out. However, NHS England has since stepped back from that position. In a clarification cited in the letter, NHS England now says:

“We cannot therefore draw conclusions about cause and effect as other variables have not been controlled for.”

This retraction is significant, as it removes one of the central pieces of evidence that had previously been used to justify the platform’s continued use, leaving the Committee to question what tangible benefits the FDP has actually delivered.

Do NHS Trusts Already Have Alternatives to the Federated Data Platform?

According to the letter, the government itself has acknowledged that some NHS trusts already possess data capabilities that exceed what the Federated Data Platform currently offers. This admission is central to the Committee’s argument, as it demonstrates that viable alternatives are not merely theoretical but are already operating in parts of the health service. The existence of these more capable systems within individual trusts suggests, in the Committee’s view, that a nationwide reliance on Palantir’s platform may not be necessary, and that a broader rollout of these existing, trust-level solutions could offer a path forward that does not require dependence on a single external contractor.

What Further Information Has the Committee Requested From the Department of Health and Social Care?

Beyond its central recommendation, the Committee has also submitted a series of specific requests to the Department of Health and Social Care. It has asked what advice the Department has received regarding the feasibility of securing a new contractor in time for March 2027, effectively probing whether the government has already begun contingency planning. The Committee has also requested that the Department provide detailed information about the assessment process it intends to carry out before making a final decision on whether to continue with Palantir and the FDP beyond the break clause. These requests suggest MPs are seeking not just a policy commitment, but a transparent and accountable decision-making process that can be scrutinised as it unfolds.
Explore More about Politics:
Andy Burnham Urges Tougher UK Action on Israel Settlements Amid Growing Pressure
Transport Committee Reacts To Government’s Ports NPS Response

What Did the Health and Social Care Committee Chair Say?

Health and Social Care Committee Chair Layla Moran MP offered a pointed assessment of the government’s position, stating:

“Little by little, the government’s arguments for sticking with the FDP has unravelled. So in the interest of public confidence in the NHS and the security of their medical information, we believe it is time to crack on with preparations to find an alternative in time for spring 2027. The FDP may have had some advantages, but there are also downsides and it is evidently not the only show in town.”

Her comments reflect the broader tone of the Committee’s letter, acknowledging that the platform may have delivered some value while insisting that its drawbacks, combined with the erosion of the evidence base supporting it, now outweigh the case for its continued use.

What Happens Next for the Palantir Contract?

With the Committee’s letter now formally submitted to the Health Innovation Minister, attention turns to how the Department of Health and Social Care will respond. The government has not yet indicated whether it will accept the Committee’s recommendation to drop the FDP at the February 2027 break clause, nor has it confirmed timelines for identifying a potential replacement. The Committee’s requests for further information, including on contractor feasibility and the government’s own assessment process, are likely to shape the next phase of scrutiny. For now, the onus is on ministers to respond to MPs’ concerns and to set out a clear plan for how, and whether, the NHS will continue its relationship with Palantir beyond the contractual window that opens in spring 2027.